We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $688M
1-Year Est. Return 63.4%
This Fund
S&P 500
This Quarter Est. Return
+23.71%
1 Year Est. Return
+63.4%
3 Year Est. Return
+248.3%
5 Year Est. Return
+571.65%
10 Year Est. Return
+5,300.27%
AUM
$642M
AUM Growth
+$86.9M
Cap. Flow
+$11M
Cap. Flow %
1.72%
Top 10 Hldgs %
35.11%
Holding
408
New
173
Increased
29
Reduced
65
Closed
84

Sector Composition

Rank Sector Weight
1 Financials 22.59%
2 Technology 9.79%
3 Consumer Discretionary 7.01%
4 Industrials 6.44%
5 Healthcare 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AONE.WS
301
DELISTED
one Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of
AONE.WS
$42K 0.01%
+19,778
New +$33.4K
ZGYHW
302
DELISTED
Yunhong International Warrant
ZGYHW
$41K 0.01%
55,100
-12,600
-19% -$4.46K
OPK icon
303
Opko Health
OPK
$1.04B
$40K 0.01%
10,000
BREZR
304
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
$37K 0.01%
+128,600
New +$34.9K
TMPOW
305
DELISTED
Tempo Automation Holdings, Inc. Warrant
TMPOW
$37K 0.01%
26,550
ASPL.WS
306
DELISTED
Aspirational Consumer Lifestyle Corp. Redeemable Warrants, each whole warrant exercisable for one Cl
ASPL.WS
$37K 0.01%
+34,600
New +$34.7K
SNPR.WS
307
DELISTED
Tortoise Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary shar
SNPR.WS
$36K 0.01%
+12,600
New +$28.5K
ZGYHR
308
DELISTED
Yunhong International Right
ZGYHR
$34K 0.01%
110,100
-25,300
-19% -$6.06K
OACB.WS
309
DELISTED
Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share
OACB.WS
$25K ﹤0.01%
+12,975
New +$18.3K
GIX.RT
310
DELISTED
GigCapital2, Inc. Rights, each exchangeable into one-twentieth of a share of Common Stock
GIX.RT
$25K ﹤0.01%
60,000
-143,500
-71% -$44K
ASAQ.WS
311
DELISTED
Atlantic Avenue Acquisition Corp Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ASAQ.WS
$23K ﹤0.01%
+20,550
New +$15.1K
PACE.WS
312
DELISTED
TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary
PACE.WS
$22K ﹤0.01%
+10,300
New +$24.4K
ADN
313
DELISTED
Advent Technologies
ADN
-1,156
Closed -$359K
ADNWW
314
DELISTED
Advent Technologies Holdings Warrant
ADNWW
-162,381
Closed -$110K
AEVA
315
Aeva Technologies
AEVA
$1.56B
-59,840
Closed -$2.99M
ASLE icon
316
AerSale
ASLE
$273M
-167,505
Closed -$1.72M
AVPT icon
317
AvePoint
AVPT
$2.91B
-270,311
Closed -$2.87M
BIO icon
318
Bio-Rad Laboratories Class A
BIO
$9.66B
-400
Closed -$206K
CCB icon
319
Coastal Financial
CCB
$774M
-47,800
Closed -$586K
CLOV icon
320
Clover Health Investments
CLOV
$2.38B
-180,000
Closed -$2.24M
CORT icon
321
Corcept Therapeutics
CORT
$11.9B
-13,400
Closed -$233K
ELV icon
322
Elevance Health
ELV
$86.4B
-750
Closed -$201K
MPC icon
323
Marathon Petroleum
MPC
$100B
-23,500
Closed -$689K
OPEN icon
324
Opendoor
OPEN
$3.54B
-28,417
Closed -$522K
FIRY
325
Firy Inc
FIRY
$158M
-4,645
Closed -$1.13M

Similar funds

Gabelli & Co Investment Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Gabelli & Co Investment Advisers held 408 positions worth $642M, up 16% from $555M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Gabelli & Co Investment Advisers's Q4 2020 filing shows 173 new, 29 increased, 65 reduced and 84 closed positions. Its largest new stake was Slack Technologies, Inc.: 509,889 shares worth $21.5M. The largest sale was Momenta Pharmaceuticals, Inc., an estimated $22.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Gabelli & Co Investment Advisers's largest Q4 2020 buy was Slack Technologies, Inc.: 509,889 shares worth $21.5M.
  • Gabelli & Co Investment Advisers added most to Tiffany & Co. in Q4 2020, an estimated $8.12M increase.
  • Gabelli & Co Investment Advisers's biggest Q4 2020 reduction was Sina Corp, cutting an estimated $2.89M.
  • Gabelli & Co Investment Advisers fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $22.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 35% of its $642M portfolio in Q4 2020.
  • Gabelli & Co Investment Advisers opened 173 new positions and closed 84 in Q4 2020.
  • Gabelli & Co Investment Advisers's portfolio value rose 16% quarter-over-quarter to $642M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2020, filed 5 Feb 2021.